| Reference number |
2026-03071 |
| Coordinator |
Pharmnovo AB |
| Funding from Vinnova |
SEK 15 000 |
| Project duration |
September 2026 - October 2026
|
| Status |
Ongoing |
| Call |
Travel grant Vinnova 2026 |
Important results from the project
The goals were met to the extent that a number of new contacts were made that will be followed up.
Expected long term effects
To establish long-term contacts with pharmaceutical companies for a possible future partnership.
Approach and implementation
It is of great importance that our company is at the relevant congresses and tells investors about our project, which can change so much for all the people around the world who have problems with pain in some form. Our studies also show that there is no addiction problem with PN6047. The structure is the same for this type of congresses. We try to book personal meetings with investors before the congress and also prepare a pitch to reach many participants.
External links
The project description has been provided by the project members themselves and the text has not been looked at by our editors.
